MPC
38
5
DG
29
12
TXN
35
7
CAG
53
12
AMP
43
3
CMA
50
4
PWR
60
4
CNP
49
2
NEE
46
4
CSX
39
2
QCOM
52
4
SIG
41
-2
IRM
30
2
FOXA
67
3
WU
28
2
CF
56
6
LYB
34
16
MSFT
46
3
HST
35
2
CPB
32
-2
MPC
38
5
DG
29
12
TXN
35
7
CAG
53
12
AMP
43
3
CMA
50
4
PWR
60
4
CNP
49
2
NEE
46
4
CSX
39
2
QCOM
52
4
SIG
41
-2
IRM
30
2
FOXA
67
3
WU
28
2
CF
56
6
LYB
34
16
MSFT
46
3
HST
35
2
CPB
32
-2
Financhill
Back

Day One Biopharmaceuticals 10K Form

Sell
25

DAWN
Day One Biopharmaceuticals

Last Price:
$12.59
Seasonality Move:
-21.51%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive DAWN News And Ratings

See the #1 stock for the next 7 days that we like better than DAWN

DAWN Financial Statistics

Sales & Book Value

Annual Sales: --
Cash Flow: $-5M
Price / Cash Flow: 0
Annual Sales: $5.51
Price / Book: 2.29

Profitability

EPS (TTM): -1.03000
Net Income (TTM): $-84.3M
Gross Margin: --
Return on Equity: 0%
Return on Assets: 0%

Day One Biopharmaceuticals Earnings Forecast

Key Day One Biopharmaceuticals Financial Ratios

  • The Interest Expense is -0.07% of Operating Income.
  • Per Share Earnings over the last 5 years have been positive in 1 years.

Day One Biopharmaceuticals Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: DAWN
Website: dayonebio.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 14.62
Quick Ratio: 14.27

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

DAWN Technical Analysis vs Fundamental Analysis

Sell
25
Day One Biopharmaceuticals (DAWN) is a Sell

Is Day One Biopharmaceuticals a Buy or a Sell?